Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Impaired exercise performance in systemic sclerosis and its clinical correlations.

Cuomo G, Santoriello C, Polverino F, Ruocco L, Valentini G, Polverino M.

Scand J Rheumatol. 2010 Aug;39(4):330-5. doi: 10.3109/03009740903555358.

PMID:
20476863
2.

Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement.

de Oliveira NC, dos Santos Sabbag LM, Ueno LM, de Souza RB, Borges CL, de Sá Pinto AL, Lima FR.

Scand J Rheumatol. 2007 Nov-Dec;36(6):458-61.

PMID:
18092268
3.

Exercise in systemic sclerosis intensifies systemic inflammation and oxidative stress.

Hargardóttir H, van Helvoort HA, Vonk MC, van den Hoogen FH, Dekhuijzen PN, Heijdra YF.

Scand J Rheumatol. 2010;39(1):63-70. doi: 10.3109/03009740903124416.

PMID:
20132073
4.

Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.

Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA Jr, Steen V, Martin R, Collier D, Weinstein A, Lally E, Varga J, Weiner S, Andrews B, Abeles M, Seibold J.

Arthritis Rheum. 1999 Nov;42(11):2372-80.

5.

Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.

Beretta L, Santaniello A, Lemos A, Masciocchi M, Scorza R.

Rheumatology (Oxford). 2007 Feb;46(2):296-301. Epub 2006 Jul 28.

PMID:
16877463
6.

Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.

Johnson SR, Glaman DD, Schentag CT, Lee P.

J Rheumatol. 2006 Jun;33(6):1117-22.

PMID:
16622903
7.

Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis.

Kuwana M, Sato S, Kikuchi K, Kawaguchi Y, Fujisaku A, Misaki Y, Hatamochi A, Kondo H, Takehara K.

J Rheumatol. 2003 Jun;30(6):1253-8.

PMID:
12784399
9.

The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.

Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA Jr, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Seibold JR.

Arthritis Rheum. 2001 Mar;44(3):653-61.

10.

Failure of the circulatory system limits exercise performance in patients with systemic sclerosis.

Sudduth CD, Strange C, Cook WR, Miller KS, Baumann M, Collop NA, Silver RM.

Am J Med. 1993 Oct;95(4):413-8.

PMID:
8213874
11.

Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.

D'Andrea A, Bellissimo S, Scotto di Uccio F, Vigorito F, Moscato F, Tozzi N, Di Donato M, Citro R, Stisi S, Scherillo M.

Ital Heart J. 2004 Nov;5(11):831-9.

PMID:
15633438
12.
13.

Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure.

Di Salvo TG, Mathier M, Semigran MJ, Dec GW.

J Am Coll Cardiol. 1995 Apr;25(5):1143-53.

14.

Impairment of exercise capacity and peak oxygen consumption in patients with mild left ventricular dysfunction and coronary artery disease.

Nieuwland W, Berkhuysen MA, van Veldhuisen DJ, van Sonderen E, Viersma JW, Lie KI, Rispens P.

Eur Heart J. 1998 Nov;19(11):1688-95.

PMID:
9857922
15.

Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers.

Del Rosso A, Boldrini M, D'Agostino D, Placidi GP, Scarpato A, Pignone A, Generini S, Konttinen Y, Zoppi M, Vlak T, Placidi G, Matucci-Cerinic M.

Arthritis Rheum. 2004 Jun 15;51(3):475-81.

16.

Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.

Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, Korn JH, Merkel PA, Rothfield N, Wigley FM, Moreland LW, Silver R, Steen VD, Weisman M, Mayes MD, Collier DH, Medsger TA Jr, Seibold JR; Relaxin Study Group; Scleroderma Clinical Trials Consortium.

J Rheumatol. 2005 May;32(5):832-40.

PMID:
15868618
17.

Using a self-reported functional score to assess disease progression in systemic sclerosis.

Serednicka K, Smyth AE, Black CM, Denton CP.

Rheumatology (Oxford). 2007 Jul;46(7):1107-10. Epub 2007 Apr 10.

PMID:
17426141
18.

[Hypocomplementemia in systemic sclerosis].

Cuomo G, Abignano G, Ruocco L, Vettori S, Valentini G.

Reumatismo. 2008 Oct-Dec;60(4):268-73. Italian.

19.

[HAQ-DI Italian version in systemic sclerosis].

La Montagna G, Cuomo G, Chiarolanza I, Ruocco L, Valentini G.

Reumatismo. 2006 Apr-Jun;58(2):112-5. Italian.

20.

Patient preference disability questionnaire in systemic sclerosis: a cross-sectional survey.

Mouthon L, Rannou F, Bérezné A, Pagnoux C, Guilpain P, Goldwasser F, Revel M, Guillevin L, Fermanian J, Poiraudeau S.

Arthritis Rheum. 2008 Jul 15;59(7):968-73. doi: 10.1002/art.23819.

Supplemental Content

Support Center